Full Text
Economic Evaluation Of Dabigatran Etexilate Versus Warfarin, Rivaroxaban And Apixaban In Stroke Prevention In Atrial Fibrilation

Abstract

Authors

J.L. Huicochea-Bartelt J. Gay-Molina L.A. Ortiz-Blas S. Herran

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×